Module 7: Chronic harms and management of SCRAs and hallucinogens

by Dr Dima Abdulrahim, Dr David Wood, Dr Sarah Finlay and Dr Owen Bowden-Jones, on behalf of the NEPTUNE group


Published: September 2017


This module is aimed at clinicians who are likely to come into contact with people presenting to hospital with chronic harms resulting from the use of novel psychoactive substances (NPS) and club drugs.


Specifically, this module provides learning about the impact of long-term and frequent use of synthetic cannabinoid receptor agonists (SCRAs) and hallucinogens on physical and psychological health, with a focus on harmful use and dependence, and considers the management of these substance misuse-related problems.


Start the module


© 2020 NEPTUNE